0.00Open8.50Pre Close0 Volume1 Open Interest86.00Strike Price0.00Turnover101.73%IV0.63%PremiumDec 6, 2024Expiry Date8.01Intrinsic Value100Multiplier4DDays to Expiry0.49Extrinsic Value100Contract SizeAmericanOptions Type-0.7572Delta0.0361Gamma9.18Leverage Ratio-0.3197Theta-0.0071Rho-6.95Eff Leverage0.0267Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet